In a significant legal decision, the US Supreme Court has ruled in favour of Bayer, the parent company of Monsanto, effectively blocking thousands of lawsuits that claim the herbicide Roundup, which contains glyphosate, is linked to cancer. The court’s ruling, delivered on June 25, 2026, comes as a blow to many individuals alleging harm from the widely used weed killer.
Supreme Court Decision Overview
The case, Monsanto v Durnell, was decided by a 7-2 majority, with Justice Brett Kavanaugh penning the majority opinion. His ruling asserts that the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) preempts state law claims regarding the company’s failure to provide adequate warnings about the potential risks associated with glyphosate. Justice Ketanji Brown Jackson dissented, supported by Justice Neil Gorsuch, arguing that FIFRA does not entirely strip states of their regulatory authority over pesticide labels.
Justice Kavanaugh’s opinion highlights that since the Environmental Protection Agency (EPA) has not mandated cancer warnings for glyphosate-based products, the state law claims brought forth by individuals cannot proceed. Jackson’s dissent, however, emphasises that while FIFRA limits state authority, it does not eliminate it entirely, thus leaving individuals without recourse for alleged significant harms.
Context of the Lawsuits
The ruling addresses a wave of litigation against Bayer, which has been embroiled in over 100,000 lawsuits concerning its glyphosate products. Plaintiffs allege that exposure to glyphosate has led to non-Hodgkin lymphoma and other serious health issues. The herbicide has been under scrutiny since the World Health Organization classified it as a probable human carcinogen in 2015.
Bayer has consistently maintained that its products are safe and that the EPA’s stance—labeling glyphosate as “unlikely” to be carcinogenic—supports its position. The company’s legal team argues that because the EPA has not required cancer warnings, there is no basis for liability regarding failure to warn users.
Reactions to the Ruling
Following the ruling, Bayer hailed the decision as a victory for science and regulatory clarity, asserting that it will help contain ongoing Roundup litigation. The company claimed the ruling would dismiss current and prevent future failure-to-warn claims against it.
Conversely, environmental and public health advocates have condemned the decision. Patti Goldman, a senior attorney at Earthjustice, stated that EPA approval does not equate to product safety and should not exempt companies from disclosing potential risks. Critics like Tarah Heinzen from Food and Water Watch voiced concerns that the ruling prioritises corporate interests over public health and environmental considerations.
Additionally, thousands of similar claims against pesticide manufacturer Syngenta regarding its herbicide paraquat have also been impacted by this ruling. Plaintiffs in those cases allege that exposure to paraquat has resulted in Parkinson’s disease, a connection that Syngenta disputes as unsupported by conclusive evidence.
Ongoing Advocacy and Future Implications
Despite the setback, advocacy groups and individuals affected by these products remain resolute. Farm Action, a farmer-led advocacy group, expressed disappointment but vowed to continue fighting for justice against corporate power that undermines public safety. Angela Huffman, the group’s president, articulated the ongoing struggle for individuals’ rights to seek legal recourse.
Nathan Donley, from the Center for Biological Diversity, highlighted the need for reform in pesticide regulation, arguing that the ruling underscores the importance of a more protective EPA that prioritises public health over the interests of pesticide manufacturers.
Why it Matters
This Supreme Court ruling not only sets a precedent for how pesticide-related lawsuits can be pursued but also raises critical questions about the balance of power between regulatory agencies and corporate entities. As Bayer and other companies face mounting litigations, the decision could significantly shape the future of public health advocacy and environmental safety standards. The implications extend beyond glyphosate, potentially affecting how other hazardous substances are regulated and litigated in the United States, thereby influencing the broader landscape of consumer rights and corporate accountability.
